Feline 1-HCPCh
Shown to be effective against several important feline viruses as well as feline Chlamydophila felis*.
Product Description
FELINE 1-HCPCh Vaccine provides protection against important feline viruses
Feline Rhinotracheitis Virus, Feline Calicivirus, Feline Panleukopenia Virus (modified live viruses), Chlamydophila felis* (avirulent live bacteria).
- A quality core vaccine shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses, as well as feline Chlamydophila
- Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats1
- Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia61-63
- Non-adjuvanted formula
- Optimal for healthy outdoor cats or cats that board frequently
Indications:
Shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses, as well as feline Chlamydophila*.
*Previously known as Chlamydia psittaci.
ADMINISTRATION AND DOSAGE
- Subcutaneous or intramuscular injection
- Initial 1 mL dose administered at 9 weeks of age or older
- Second 1 mL dose administered 3 to 4 weeks later
- Contact your veterinarian or manufacturer for more information on revaccination frequency.
- Available in a 25 x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
View More Nobivac ResourcesReferences
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global